You are here

  • Home
  • Archive
  • Volume 25, Issue 5
  • Comparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study

Citation Tools

Article menu
Download PDFPDF
Original Articles
Comparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Dahm P, Lundborg C, Janson M, et al
Comparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study
Regional Anesthesia & Pain Medicine 2000;25:480-487.